Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical)

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
General and administrative costs, to related parties $ 784,390 $ 12,000 $ 808,390 $ 41,691
Research and development costs, to Theradex $ 804 $ 40,225 $ 804 $ 104,840